The Irving Institute is currently accepting applications for several pilot funding programs.

Applications are due November 1, 2017
TRx pre-proposals are due December 1, 2017

Visit here for more information.

title_pcsr
funding education mentorship mentorship mentorship

Now Accepting Pre-Proposals - 2018 TRx Pilot Awards

Due Date: Friday, December 1, 2017 by 5:00pm EST

Pre-Proposal Instructions: Download
Pre-Proposal Submission: Start a pre-proposal

  trx

The Translational Therapeutics (TRx) Resource is an accelerator program designed to leverage Columbia’s proficiency in drug discovery and provide access to Entrepreneurs and the pharmaceutical industry to advance novel therapeutics from the lab towards the path of commercialization and clinical implementation.

Academic therapeutic projects often fall within the “Valley of Death”, where it is exceedingly difficult to obtain outside funding. This collaboration between the Irving Institute for Clinical and Translational Research, Columbia Technology Ventures and The Clinical Trials Office will provide education, mentorship and funding to help academic translational research projects move beyond the valley of death and reach significant milestones. A key goal of this program is to accelerate translation of novel medical discoveries from the lab to the clinic by positioning the technology for commercialization.

The TRx Resource is a centralized resource for Columbia Faculty and students motivated to move discoveries through drug development pathway. 

TRx Programs and Services

FUNDING

MENTORSHIP

EDUCATION

The TRx Resource Pilot Award provides up to $75,000 for therapeutic drug development The TRx Development Teams are project specific teams that will include members of industry, executives-in-residence and Columbia scientists The TRx Boot Camp and Seminar series will give an overview of the hurdles in the path from drug discovery to drug development and commercialization

 

For any questions please contact:
TRxresource@columbia.edu